Allo Non-Myeloablative SCT Utilizing Mis-Matched Family Member Stem Cells Purged Using Campath

NCT00580034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

176

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma
Myeloma
Leukemia
Myelodysplasia
Solid Tumors

Interventions

DRUG: Campath Purged Non-myeloablative ASCT
PROCEDURE: Donor Apheresis

Sponsor

David Rizzieri, MD

Collaborators

[object Object]